Royal Bank Raises Price Target for American Healthcare REIT

American Healthcare REIT (NYSE:AHR) has seen its price target raised by analysts at Royal Bank Of Canada to $61.00, a potential upside of 13.20% from the stock's current price.

This revised target is part of a broader trend in which several firms have updated their views on AHR in recent weeks. On June 2nd, Weiss Ratings downgraded American Healthcare REIT from 'buy' to 'hold,' while Compass Point assumed coverage and set a $70.00 price target.

Citigroup reaffirmed its 'buy' rating with a higher price objective of $65.00, up from $55.00, in a report on Monday. Citizens Jmp also raised their price objective to $65.00 while maintaining a 'market outperform' rating.